Form D Explorer

Inspect source fieldsReport a record issue

Form D — Iaso Therapeutics, Inc.

0000905729-26-000020 · filed Jan 14, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$1,800,000
Reported amount sold
$570,000
Minimum investment
$25,000
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Iaso Therapeutics, Inc.
CIK
1961165
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
4942 DAWN AVE
EAST LANSING, Michigan 48823
Phone
773-437-0274

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗